blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4309739

EP4309739 - CORE/SHELL STRUCTURE PLATFORM FOR IMMUNOTHERAPY [Right-click to bookmark this link]
StatusThe application has been published
Status updated on  22.12.2023
Database last updated on 09.09.2024
Most recent event   Tooltip01.05.2024New entry: Additional fee for renewal fee: despatch of communication + time limit 
Applicant(s)For all designated states
The Methodist Hospital
6565 Fannin Street, MS D200
Houston, Texas 77030 / US
[2024/04]
Inventor(s)01 / Shen, Haifa
Bellaire, TX 77401 / US
 [2024/12]
Representative(s)Forresters IP LLP
Skygarden
Erika-Mann-Straße 11
80636 München / DE
[2024/04]
Application number, filing date23214393.326.01.2018
[2024/04]
Priority number, dateUS201762451575P27.01.2017         Original published format: US 201762451575 P
[2024/04]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP4309739
Date:24.01.2024
Language:EN
[2024/04]
Type: A3 Search report 
No.:EP4309739
Date:17.04.2024
Language:EN
[2024/16]
Search report(s)(Supplementary) European search report - dispatched on:EP18.03.2024
ClassificationIPC:A61K39/39, A61K9/127, A61K9/51, A61P35/00
[2024/16]
CPC:
A61K9/1271 (EP,KR,US); A61K39/0011 (KR,US); A61K39/001104 (US);
A61K39/001106 (US); A61K39/001156 (US); A61K39/39 (EP,KR,US);
A61K39/4612 (EP); A61K39/4614 (EP); A61K39/4615 (EP);
A61K39/4622 (EP); A61K39/464406 (EP); A61K39/46449 (EP);
A61K45/06 (US); A61K47/645 (EP,US); A61K47/6925 (EP,US);
A61K9/127 (US); A61K9/5015 (KR); A61P35/00 (EP,KR,US);
A61K2039/53 (EP,KR,US); A61K2039/55533 (EP,US); A61K2039/55555 (EP,KR,US);
A61K2039/6018 (KR); A61K9/0019 (EP,US); A61K9/0021 (EP,US) (-)
Former IPC [2024/04]A61P35/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/04]
TitleGerman:KERN-SCHALE-STRUKTURPLATTFORM FÜR DIE IMMUNTHERAPIE[2024/04]
English:CORE/SHELL STRUCTURE PLATFORM FOR IMMUNOTHERAPY[2024/04]
French:PLATE-FORME DE STRUCTURE C UR/ÉCORCE POUR IMMUNOTHÉRAPIE[2024/04]
Parent application(s)   TooltipEP18715827.4  / EP3573656
EP21210308.9  / EP4008344
Fees paidRenewal fee
05.12.2023Renewal fee patent year 03
05.12.2023Renewal fee patent year 04
05.12.2023Renewal fee patent year 05
05.12.2023Renewal fee patent year 06
17.04.2024Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
31.01.202407   M06   Fee paid on   17.04.2024
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2015011633  (PROTIVA BIOTHERAPEUTICS INC [CA], et al);
by applicantUS4554101
 US5399363
 US5543158
 US5641515
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.